Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
601628 China Life Insurance
- 44.15
- +0.89+2.06%
Not Open Dec 12 15:00 CST
1.25TMarket Cap14.26P/E (TTM)
44.77High43.02Low163.12KlotVolume43.18Open43.26Pre Close715.04MTurnover0.08%Turnover Ratio59.10P/E (Static)28.26BShares50.6852wk High2.22P/B919.36BFloat Cap24.4652wk Low47.59Limit Up20.82BShs Float68.80Historical High38.93Limit Down4.05%Amplitude7.82Historical Low0.63Dividend TTM43.84Avg Price64.82KlotAsk1.43%Div YieldTTM100Lot Size87.19KlotBid
China Life Insurance Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Premiums received from original insurance contracts | 2.55%679.57B | 7.59%514.02B | 7.81%324.93B | 3.52%639.67B | 34.02%662.66B | 30.83%477.78B | 28.23%301.4B | 0.21%617.9B | 2.04%494.46B | 0.42%365.18B |
| Net cash received from reinsurance business | --215M | -39.29%136M | ---- | ---- | ---- | --224M | --20M | ---- | ---- | ---- |
| Net increase in deposits from policyholders | ---- | ---- | ---- | 98.87%94.38B | ---- | ---- | ---- | 267.38%47.46B | 221.93%38.44B | 192.45%27.42B |
| Cash received relating to other operating activities | 12.55%9.1B | 1.31%7.48B | 6.10%5.55B | -36.80%11.28B | -37.95%8.09B | -35.03%7.38B | 57.96%5.23B | 23.85%17.86B | 34.86%13.04B | 93.77%11.36B |
| Special items of operating cash inflws | ---- | --91M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from operating activities | 2.70%688.89B | 7.49%521.73B | 7.77%330.48B | 8.59%745.33B | 22.44%670.75B | 19.58%485.38B | 16.51%306.65B | 6.59%686.39B | 8.16%547.8B | 5.86%405.89B |
| Staff behalf paid | -5.77%18.66B | -5.74%12.26B | -4.59%5.88B | -1.83%25.84B | -2.03%19.8B | -6.26%13.01B | -5.21%6.17B | 9.13%26.32B | 10.23%20.21B | 8.99%13.88B |
| All taxes paid | 6.17%5.2B | 20.33%3.53B | -10.11%1.27B | -7.16%5.78B | -10.73%4.89B | -20.37%2.93B | -33.97%1.42B | -48.46%6.23B | -59.88%5.48B | -65.47%3.68B |
| Cash paid for fees and commissions | -6.22%51.1B | -3.00%37.81B | -2.83%21.61B | 13.48%62.88B | 17.51%54.49B | 11.41%38.98B | 2.55%22.24B | -17.79%55.41B | -17.40%46.37B | -18.29%34.99B |
| Cash paid for indemnity of original insurance contract | 14.19%251.06B | 15.87%175.57B | 19.66%109.2B | 25.28%217.72B | 65.24%219.87B | 71.47%151.53B | 85.77%91.26B | -1.41%173.78B | -2.35%133.07B | -5.24%88.37B |
| Net cash for reinsurance | ---- | ---- | --24M | -62.12%486M | -60.64%416M | ---- | ---- | 35.34%1.28B | 105,600.00%1.06B | 250.68%519M |
| Policy dividend cash paid | ---- | ---- | ---- | -8.07%19.88B | ---- | ---- | ---- | -9.98%21.62B | -7.78%17.8B | -7.24%11.68B |
| Net increase in financial assets held for trading purposes | ---- | ---- | ---- | -98.48%413M | ---- | ---- | ---- | --27.14B | ---- | ---- |
| Cash paid relating to other operating activities | -20.50%12.5B | -10.97%12.01B | -22.80%5.71B | -3.18%21.92B | -19.49%15.73B | 34.11%13.49B | 44.24%7.39B | -13.65%22.64B | 22.45%19.53B | -5.52%10.06B |
| Special items of operating cash outflws | -73.80%3.77B | ---- | 37.62%3.03B | ---- | --14.4B | --8.78B | --2.2B | ---- | ---- | ---- |
| Cash outflows from operating activities | -1.01%342.28B | 2.21%241.17B | 12.29%146.72B | 6.78%357.1B | 33.52%345.77B | 44.60%235.96B | 47.11%130.67B | -6.45%334.42B | -0.43%258.97B | -11.84%163.18B |
| Net cash flows from operating activities | 6.65%346.6B | 12.48%280.55B | 4.42%183.76B | 10.30%388.23B | 12.52%324.98B | 2.76%249.42B | 0.92%175.98B | 22.87%351.97B | 17.23%288.83B | 22.39%242.71B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 73.05%1.7T | 58.71%1.1T | 45.72%531.12B | 3.71%1.2T | 5.31%979.94B | 24.10%690.72B | 5.00%364.49B | 67.27%1.16T | 89.90%930.54B | 82.14%556.57B |
| Cash received from returns on investments | -2.21%133.76B | -1.78%88.87B | -12.89%36.38B | 2.07%191.41B | 1.70%136.78B | 2.87%90.48B | -8.27%41.77B | 7.47%187.52B | 10.76%134.5B | 14.59%87.95B |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -47.06%45M | 46.27%98M | 155.00%51M | 189.53%1.05B | -42.57%85M | -32.32%67M | -25.93%20M | 6.45%363M | -40.08%148M | -59.43%99M |
| Net cash received from disposal of subsidiaries and other business units | --5.45B | --2.9B | 510.00%183M | ---- | ---- | ---- | --30M | 686.23%4.4B | -46.99%255M | ---- |
| Special items of investing cash inflows | ---- | ---- | --4.86B | --21.84B | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 64.31%1.84T | 52.08%1.19T | 40.93%572.6B | 4.81%1.42T | 4.82%1.12T | 21.20%781.26B | 3.47%406.31B | 55.64%1.35T | 74.04%1.07T | 68.49%644.63B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 28.22%2.52B | 121.27%2.57B | 128.95%1.65B | 35.60%4.17B | 14.36%1.97B | -14.44%1.16B | 30.32%722M | -44.90%3.08B | -44.64%1.72B | -38.93%1.36B |
| Cash paid to acquire investments | 52.06%2.13T | 49.31%1.38T | 22.04%569.69B | 24.90%1.79T | 29.75%1.4T | 27.00%923.59B | 36.19%466.81B | 21.23%1.43T | 25.22%1.08T | 27.18%727.22B |
| Net cash paid to acquire subsidiaries and other business units | -6.71%10.27B | -6.56%7.25B | -37.06%1.23B | -2.01%34.04B | -9.17%11.01B | -32.70%7.76B | 1,436.22%1.95B | -3.28%34.74B | -7.50%12.12B | -11.73%11.53B |
| Impawned loan net increase | ---- | ---- | ---- | -11.64%16.08B | ---- | ---- | ---- | -48.71%18.2B | -51.83%12.92B | -55.69%9.25B |
| Net increase in resale business funds (investment) | --6.17B | -64.43%5.56B | ---- | ---- | ---- | -51.14%15.62B | -92.36%2.24B | 874.57%27.33B | 67.45%12.87B | 2,265.31%31.98B |
| Cash paid relating to other investing activities | ---- | ---- | ---- | --198M | --198M | --20M | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | 51.98%2.15T | 47.07%1.39T | 21.38%572.57B | 21.63%1.85T | 26.33%1.41T | 21.35%948.16B | 24.66%471.72B | 20.17%1.52T | 22.60%1.12T | 28.23%781.34B |
| Net cash flows from investing activities | -5.79%-315.47B | -23.61%-206.3B | 100.04%28M | -159.53%-428.1B | -445.97%-298.19B | -22.08%-166.9B | -557.69%-65.41B | 58.12%-164.96B | 81.88%-54.62B | 39.70%-136.71B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -42.09%10.36B | 17.43%12.73B | 22.05%8.57B | 205.89%18.04B | 451.96%17.89B | --10.84B | --7.02B | -74.20%5.9B | -81.28%3.24B | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | -42.09%10.36B | 17.43%12.73B | 22.05%8.57B | 205.89%18.04B | 451.96%17.89B | --10.84B | --7.02B | -74.20%5.9B | -81.28%3.24B | ---- |
| Cash from bonds issue | --35B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | -22.22%14M | ---- | ---- | -93.75%43M | --18M | --18M | --18M | 493.10%688M | ---- | ---- |
| Cash received relating to other financing activities | ---- | ---- | ---- | --750M | --750M | --750M | --750M | ---- | ---- | ---- |
| Net increase in repurchase funds (fundraising) | ---- | ---- | ---- | --67.13B | --5.48B | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 87.97%45.37B | 9.66%12.73B | 10.02%8.57B | 1,205.54%85.96B | 644.80%24.14B | --11.61B | --7.79B | -95.30%6.58B | -96.10%3.24B | ---- |
| Borrowing repayment | 6,139.25%35.13B | 6,429.18%35.13B | 25,079.86%35B | -93.03%577M | 480.41%563M | 627.03%538M | 101.45%139M | 75,127.27%8.28B | --97M | --74M |
| Dividend interest payment | -6.86%18.76B | 12.39%5.54B | -4.43%3.17B | -15.91%22.19B | -17.56%20.14B | -6.37%4.93B | 6.93%3.32B | -1.10%26.39B | -3.83%24.43B | 17.65%5.26B |
| Cash payments relating to other financing activities | -0.13%760M | 2.06%496M | 11.39%264M | 123.26%2.92B | -38.03%761M | -83.85%486M | -93.87%237M | -42.35%1.31B | -33.80%1.23B | 108.96%3.01B |
| Cash outflows from financing activities | 597.19%149.64B | 439.29%146.35B | 17.98%86.21B | -79.73%25.68B | -87.92%21.46B | -62.58%27.14B | -56.17%73.07B | 337.46%126.68B | 551.59%177.6B | 1,127.02%72.53B |
| Net cash flows from financing activities | -3,996.26%-104.26B | -760.48%-133.62B | -18.93%-77.64B | 150.19%60.27B | 101.53%2.68B | 78.59%-15.53B | 60.85%-65.28B | -207.98%-120.1B | -411.95%-174.36B | -235.36%-72.53B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -128.04%-30M | -91.23%10M | 136.11%13M | -70.51%64M | -53.07%107M | -44.39%114M | -28.57%-36M | 405.63%217M | 860.00%228M | 639.47%205M |
| Net increase in cash and cash equivalents | -347.38%-73.16B | -188.44%-59.36B | 134.61%106.16B | -69.51%20.47B | -50.77%29.57B | 99.29%67.11B | 106.56%45.25B | 1,687.88%67.14B | 7,018.25%60.08B | 33.94%33.68B |
| Add:Begin period cash and cash equivalents | 16.04%148.06B | 16.04%148.06B | 16.04%148.06B | 111.04%127.59B | 111.04%127.59B | 111.04%127.59B | 111.04%127.59B | 6.62%60.46B | 6.71%60.46B | 6.71%60.46B |
| End period cash equivalent | -52.34%74.9B | -54.44%88.7B | 47.08%254.22B | 16.04%148.06B | 30.39%157.17B | 106.84%194.71B | 109.85%172.84B | 111.04%127.59B | 109.63%120.54B | 15.08%94.14B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
